Faculty of Health and Medical Sciences University of Copenhagen
A 3-year PhD fellowship is available at the Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen with an expected start day 15 May 2024 or as soon as possible hereafter.
The fellowship is part of the European Marie Skłodowska-Curie Actions (MSCA) Doctoral Network BonePainIII (www. bonepain.eu). The position is 36 months and funded by the European Union's Horizon Europe Research and Innovation programme under the grant agreement No 101120524.
About BonePainIII – Identifying mechanisms and novel treatments of bone pain – closing the gap to the clinic. BonePainIII is a European Doctoral Network to promote frontline research, innovation and education within bone pain. Millions in Europe and beyond suffer from bone pain, which is a debilitating complication of many musculoskeletal disorders such as arthritis and cancer in the bone. The BonePainIII network has participants from six European countries and encompasses six academic groups and five industries , all of which are committed to creating an outstanding training program for doctoral candidates to elucidate the mechanisms of bone pain and develop new medicines.
In BonePainIII, you will be part of an international network with supervision, mentorship and research stays across sectors.
Project description The aim of the project is to identify disease mechanisms underlying pain in the rare bone disorder fibrous dysplasia and to test the in vivo efficacy of novel therapeutic approaches.
An important, but neglected aspect of bone pain is the pain of rare bone disorders. This project will focus on fibrous dysplasia, a rare bone disorder where constitutively active cAMP in bone marrow stromal cells leads to a disorganized and structurally vulnerable fibrous-osseous tissue in one or many bones. Bone pain has been reported in a majority of fibrous dysplasia patients. However, despite the impact of pain on these patients, there is limited knowledge on the underlying mechanisms, and effective treatment options.
In this project, you will 1) Use in vitro assays and human samples to identify the impact of fibrous dysplasia on the sensory neurons. 2) Employ a conditional and inducible transgenic mouse model of fibrous dysplasia to determine the anti-nociceptive efficacy of potentially novel treatments of pain in fibrous dysplasia.
This project will provide a platform for the future development of new therapeutic options for fibrous dysplasia bone pain.
Principal supervisor Professor Anne-Marie Heegaard, Department of Drug Design and Pharmacology
Start 15 May 2024 or as soon as possible hereafter.
Duration 3 years as a PhD student
Our group and research We focus on translational research in painful bone disorders such as bone metastasis and fibrous dysplasia to identify nociceptive mechanisms and novel treatment targets. The methodologies include in vitro assays, in vivo experiments and clinical studies. We strive for a positive research culture where you can develop in a supportive, collaborative environment.
Our department The Department of Drug Design and Pharmacology (www. drug.ku.dk) delivers drug-related research and research-based teaching within a wide range of drug- related disciplines, spanning the molecular, cellular, and pharmacological levels.
Job description Your key tasks as a PhD fellow at the Faculty of Health and Medical Sciences are:
Key criteria for the assessment of applicants Applicants must have qualifications corresponding to a master's degree related to the subject area of the project (at the time of employment). Please note that your master's degree must be equivalent to a Danish master's degree (two years). Experience with in vivo models and a passed course in Laboratory Animal Science EU Function ABD (formerly FELASA Category) or equivalent will be an advantage.
Applicants will also be required to meet the Marie Skłodowska-Curie Actions - Doctoral Networks eligibility criterion:
Please note that you will only be considered for the position if you fulfill the mobility rule.
Other important criteria are:
Place of employment The place of employment is at the Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen. We offer creative and stimulating working conditions in dynamic and international research environment.
Terms of employment The average weekly working hours are 37 hours per week.
The position is a fixed-term position limited to a period of 3 years and is to commence 15 May 2024 or as soon as possible hereafter.
The employment is conditioned upon the applicant's successful enrolment as a PhD student at the Graduate School at the Faculty of Health and Medical Sciences, University of Copenhagen. This requires submission and acceptance of an application for the specific project to the Graduate School of Health and Medical Sciences.
The PhD study must be completed in accordance with The Ministerial Order on the PhD programme (2013) and the Faculty's rules on achieving the degree.
Salary, pension, and terms of employment are in accordance with the requirements from the European Commission related to the MSCA programme and the agreement between the Ministry of Finance and The Danish Confederation of Professional Associations on Academics in the State. Depending on seniority, the gross monthly salary starts at approximately 28,990 DKK/roughly 3,890 EUR (taxable) plus pension (October 2023 level).
Application procedure Your application, in English, must be submitted electronically by clicking “Apply now” below and must include the following documents in PDF format:
As a prerequisite for a PhD fellowship employment, your master's degree must be equivalent to a Danish master's degree. We encourage you to read more in the assessment database: https: // ufm.dk/en/education/recognition-and- transparency/find-assessments/assessment-database. Please note that we might ask you to obtain an assessment of your education performed by the Ministry of Higher Education and Science.
Applicants with a Master´s degree from abroad should also enclose a short description of the grading scale used
The deadline for applications is Tuesday 27 February 2024, 23.59pm CET
We reserve the right not to consider material received after the deadline, and not to consider applications that do not live up to the above-mentioned requirements.
The further process After the expiry of the deadline for applications, the authorized recruitment manager selects applicants for assessment on the advice of the hiring committee. All applicants are then immediately notified whether their application has been passed for assessment by an unbiased assessor.
The assessor makes a non-prioritized assessment of the academic qualifications and experience with respect to the above-mentioned area of research, techniques, skills and other requirements listed in the advertisement. Once the assessment work has been completed each applicant has the opportunity to comment on the part of the assessment that relates to the applicant.
The applicant will be assessed according to the Ministerial Order no. 242 of 13 March 2012 on the Appointment of Academic Staff at Universities.
Interviews are expected to be held 18-22 March 2024.
You can read about the recruitment process at https: // employment.ku.dk/faculty/recruitment-process/
Questions For further information, applicants may contact the principal supervisor Professor Anne-Marie Heegaard, e-mail: [email protected], direct phone: +45 3533 6322 or PhD coordinator Marianne W. Jørgensen, e-mail: [email protected], direct phone: +45 3533 6449.
General information about PhD studies at the Faculty of Health and Medical Sciences is available at the Graduate School's website: https: // healthsciences.ku.dk/phd/guidelines/
For more information on working and living in Denmark visit https:// ism.ku.dk (International staff mobility) and https: // www. workindenmark.dk.
The University of Copenhagen wish to reflect the diversity of society and encourage all qualified candidates to apply regardless of personal background.